These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17854389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of somatostatin analogues on acromegalic cardiomyopathy: results from a prospective study using cardiac magnetic resonance.
    Bogazzi F, Lombardi M, Strata E, Aquaro G, Lombardi M, Urbani C, Di Bello V, Cosci C, Sardella C, Talini E, Martino E.
    J Endocrinol Invest; 2010 Feb; 33(2):103-8. PubMed ID: 20348836
    [Abstract] [Full Text] [Related]

  • 3. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F, Di Bello V, Palagi C, Donne MG, Di Cori A, Gavioli S, Talini E, Cosci C, Sardella C, Brogioni S, Mariani M, Martino E.
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [Abstract] [Full Text] [Related]

  • 4. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
    Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
    Pivonello R, Galderisi M, Auriemma RS, De Martino MC, Galdiero M, Ciccarelli A, D'Errico A, Kourides I, Burman P, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):476-82. PubMed ID: 17105844
    [Abstract] [Full Text] [Related]

  • 8. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
    Colao A, Pivonello R, Grasso LF, Auriemma RS, Galdiero M, Savastano S, Lombardi G.
    Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
    [Abstract] [Full Text] [Related]

  • 9. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
    Colao A, Marzullo P, Ferone D, Spinelli L, Cuocolo A, Bonaduce D, Salvatore M, Boerlin V, Lancranjan I, Lombardi G.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac hypertrophy and function in asymptomatic acromegaly.
    Morvan D, Komajda M, Grimaldi A, Turpin G, Grosgogeat Y.
    Eur Heart J; 1991 Jun; 12(6):666-72. PubMed ID: 1830550
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M, Zhao S, Jiang S, Yin G, Wang C, Zhang Y, Liu Q, Cheng H, Ma N, Zhao T, Chen X, Huang J, Zou Y, Song L, He Z, An J, Renate J, Xue H, Shah S.
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [Abstract] [Full Text] [Related]

  • 16. The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study.
    De Alcubierre D, Feola T, Cozzolino A, Pofi R, Galea N, Catalano C, Auriemma RS, Pirchio R, Pivonello R, Isidori AM, Giannetta E.
    Pituitary; 2024 Aug; 27(4):416-427. PubMed ID: 38847918
    [Abstract] [Full Text] [Related]

  • 17. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
    Seo HY, Lee SP, Park JB, Lee JM, Park EA, Chang SA, Kim HK, Park SJ, Lee W, Kim YJ, Lee SC, Park SW, Sohn DW, Choe YH.
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
    [Abstract] [Full Text] [Related]

  • 18. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH.
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R, Schwendinger D, Jung S, Pohl M, Jung B, Geiger J, Gimpel C.
    Pediatr Nephrol; 2016 Feb; 31(2):255-65. PubMed ID: 26342304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.